New Horizons in Personalized Medicine
New Horizons in Personalized Medicine Presented at: 3rd Annual Congress of the European Society for Translational Medicine, Vienna, Austria
New Horizons in Personalized Medicine Presented at: 3rd Annual Congress of the European Society for Translational Medicine, Vienna, Austria
Therapeutic exploitation of the cancer glycome: a drug discovery study.. Presented at: 3rd Annual Congress of the European Society for Translational Medicine, Vienna, Austria
Abstract Microfibrillated cellulose (MFC) has recently been explored as a novel nanostructured system for controlled drug delivery. The present study examines the releasing behavior and antibacterial efficacy of cellulose (CC) and tempo-oxidized- microfibrillated cellulose (TO-MFC) loaded with oxytetracycline at three different physiological pH (2.1, 6.8 and 9.0). The releasing mechanism from cellulosic matrix was assessed […]
Abstract Latest advances in genetics have prompted swift progress towards the efficient identification of genes tangled in complex diseases. Still, the comprehensive understanding of the relation between the physiological and molecular mechanism of genes and how they affect disease phenotypes remains a challenge for researchers and clinicians. Here, we wish to identify the osteoporosis disease […]
Abstract Despite large investments in drug development, the overall success rate of drugs during clinical development remains low. One prominent explanation is flawed preclinical research, in which the use and outcome of animal models is pivotal to bridge the translational gap to the clinic. Therefore, the selection of a validated and predictive animal model is […]
